Blockade of adenosine A1 receptors prevents methylphenidate-induced impairment of object recognition task in adult mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 1, 2011, Pages 169-176

  Mioranzza, Sabrina ^a   Costa, Marcelo S ^a   Botton, Paulo Henrique S ^a   Ardais, Ana Paula ^a   Matte, Vanessa Lague ^a   Espinosa, Janaina ^a,b   Souza, Diogo O ^a   Porciúncula, Lisiane O ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Graduation Program in Biological Sciences Neurosciences   (Brazil)

Author keywords

Adenosine receptors; Attention deficit hyperactivity disorder; Memory; Methylphenidate

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; AVOIDANCE BEHAVIOR; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; FRONTAL CORTEX; LATENT PERIOD; MALE; MEMORY DISORDER; MOUSE; NEUROTRANSMISSION; NONHUMAN; RECEPTOR BLOCKING; RECOGNITION; UPREGULATION;

ADENOSINE A1 RECEPTOR ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ESCAPE REACTION; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INHIBITION (PSYCHOLOGY); MALE; MEMORY DISORDERS; METHYLPHENIDATE; MICE; RECEPTOR, ADENOSINE A1; RECOGNITION (PSYCHOLOGY); XANTHINES;

EID: 78650981109     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.10.022     Document Type: Article

References (63)

1. Advokat C., Martino L., Guidry D. Licit and illicit use of attention-deficit hyperactivity (ADHD) medication by college students. J Am Coll Health 2008, 56:601-606.
2. Agnati L.F., Ferré S., Lluis C., Franco R., Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 2003, 55:509-550.
3. Arnsten AFT. Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Stimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press; 2001, pp. 185-208.
4. Barkley R.A., Fletcher K., Fischer M., Smallish L. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 2003, 111:97-109.
5. Bevins R.A., Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc 2006, 1:1306-1311.
6. Boeck C.R., Marques V.B., Valvassori S.S., Constantino L.C., Rosa D.V., Lima F.F. Early long-term exposure with caffeine induces cross-sensitization to methylphenidate with involvement of DARPP-32 in adulthood of rats. Neurochem Int 2009, 55:318-322.
7. Bolaños C.A., Barrot M., Berton O., Wallace-Black D., Nestler E.J. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 2003, 54:1317-1329.
8. Britton G.B., Segan A.T., Sejour J., Mancebo S. Early exposure to methylphenidate increases fear responses in an aversive context in adult rats. Dev Psychobiol 2007, 49:265-275.
9. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002, 27:699-711.
10. Canals M., Marcellino D., Fanelli F., Ciruela F., de Benedetti P., Goldberg S.R., et al. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 2003, 278:46741-46749.
11. Cao Y., Xie K.Q., Zhu X.Z. The enhancement of dopamine D1 receptor desensitization by adenosine A1 receptor activation. Eur J Pharmacol 2007, 562:34-38.
12. Costa M.S., Botton P.H., Mioranzza S., Ardais A.P., Moreira J.D., Souza D.O., et al. Caffeine improves adult mice performance in the object recognition task and increases BDNF and TrkB independent on phospho-CREB immunocontent in the hippocampus. Neurochem Int 2008, 53:89-94.
13. Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 2001, 38:107-125.
14. Dalley J.W., Lääne K., Theobald D.E., Armstrong H.C., Corlett P.R., Chudasama Y., et al. Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci 2005, 102:6189-6194.
15. Dupont R.L., Coleman J.J., Bucher R.H., Wilford B.B. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict 2008, 17:167-171.
16. El Yacoubi M., Ledent C., Parmentier M., Costentin J., Vaugeois J.M. The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists. Psychopharmacology (Berl) 2000, 148:153-163.
17. Elliott R., Sahakian B.J., Matthews K., Bannerjea A., Rimmer J., Robbins T.W. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl) 1997, 131:196-206.
18. Ferré S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 1997, 20:482-487.
19. Ferré S., Quiroz C., Woods A.S., Cunha R., Popoli P., Ciruela F., et al. An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des 2008, 14:1468-1474.
20. Ferretti V., Florian C., Costantini V.J., Roullet P., Rinaldi A., De Leonibus E., et al. Co-activation of glutamate and dopamine receptors within the nucleus accumbens is required for spatial memory consolidation in mice. Psychopharmacology 2005, 179:108-116.
21. Fleckenstein A.E., Volz T.J., Hanson G.R. Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropharmacology 2009, 56:133-138.
22. Franco R., Casado V., Cortes A., Ferrada C., Mallol J., Woods A., et al. Basic concepts in G-protein-coupled receptor homo- and heteromerization. Sci World J 2007, 7:48-57.
23. Fuxe K., Ferré S., Zoli M., Agnati L.F. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res Rev 1998, 26:258-273.
24. Fuxe K., Ferré S., Genedani S., Franco R., Agnati L.F. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav 2007, 92:210-217.
25. Gatley S.J., Volkow N.D., Gifford A.N., Fowler J.S., Dewey S.L., Ding Y.S., et al. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology (Berl) 1999, 146:93-100.
26. GineS., Hillion J., Torvinen M., Le Crom S., Casadó V., Canela E.I., et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 2000, 97:8606-8611.
27. Godfrey J. Safety of therapeutic methylphenidate in adults: a systematic review of the evidence. J Psychopharmacol 2009, 23:194-205.
28. Gomes K.M., Comim C.M., Valvassori S.S., Réus G.Z., Inácio C.G., Martins M.R., et al. Diurnal differences in memory and learning in young and adult rats treated with methylphenidate. J Neural Transm 2010, 117:457-462.
29. Guerriero R., Hayes M., Dhaliwal S., Ren J., Kosofsky B. Preadolescent methylphenidate versus cocaine treatment differ in the expression of cocaine-induced locomotor sensitization during adolescence and adulthood. Biol Psychiatry 2006, 60:1171-1180.
30. Heyser C.J., Pelletier M., Ferris J.S. The effects of methylphenidate on novel object exploration in weanling and periadolescent rats. Ann NY Acad Sci 2004, 1021:465-469.
31. Jain R., Holtzman S.G. Caffeine induces differential cross tolerance to the amphetamine-like discriminative stimulus effects of dopaminergic agonists. Brain Res Bull 2005, 65:415-421.
32. Koda K., Ago Y., Cong Y., Kita Y., Takuma K., Matsuda T. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 2010, 114:259-270.
33. Kurscheidt J.C., Peiler P., Behnken A., Abel S., Pedersen A.T., Suslow T., et al. Acute effects of methylphenidate on neuropsychological parameters in adults with ADHD: possible relevance for therapy. J Neural Transm 2008, 115:357-362.
34. Kuzmin A., Johansson B., Zvartau E.E., Fredholm B.B. Caffeine, acting on adenosine A(1) receptors, prevents the extinction of cocaine-seeking behavior in mice. J Pharmacol Exp Ther 1999, 290:535-542.
35. LeBlanc-Duchin D., Taukulis H.K. Chronic oral methylphenidate administration to periadolescent rats yields prolonged impairment of memory for objects. Neurobiol Learn Mem 2007, 88:312-320.
36. LeBlanc-Duchin D., Taukulis H.K. Chronic oral methylphenidate induces post-treatment impairment in recognition and spatial memory in adult rats. Neurobiol Learn Mem 2009, 91:218-225.
37. Madras B.K., Miller G.M., Fischman A.J. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1397-1409.
38. Maggio R., Aloisi G., Silvano E., Rossi M., Millan M.J. Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance. Parkinsonism Relat Disord 2009, (Suppl 4):S2-S7.
39. McFadyen-Leussis M.P., Lewis S.P., Bond T.L., Carrey N., Brown R.E. Prenatal exposure to methylphenidate hydrochloride decreases anxiety and increases exploration in mice. Pharmacol Biochem Behav 2004, 77:491-500.
40. Mehta M.A., Calloway P., Sahakian B.J. Amelioration of specific working memory deficits by methylphenidate in a case of adult attention deficit/hyperactivity disorder. J Psychopharmacol 2000, 14:299-302.
41. 1 receptors are modified by acute treatment with methylphenidate in adult mice. Brain Res 2010, 1357:62-69.
42. Pascoli V., Valjent E., Corbillé A.G., Corvol J.C., Tassin J.P., Girault J.A., et al. cAMP and extracellular signal-regulated kinase signaling in response to d-amphetamine and methylphenidate in the prefrontal cortex in vivo: role of beta 1-adrenoceptors. Mol Pharmacol 2005, 68:421-429.
43. Pires V.A., Pamplona F.A., Pandolfo P., Fernandes D., Prediger R.D., Takahashi R.N. Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder. Behav Pharmacol 2009, 20:134-145.
44. Poleszak E., Malec D. Effects of adenosine receptor agonists and antagonists in amphetamine-induced conditioned place preference test in rats. Pol J Pharmacol 2003, 55:319-326.
45. Popoli P., Pèzzola A., de Carolis A.S. Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats. Eur J Pharmacol 1994, 257:21-25.
46. Prediger R.D., Pamplona F.A., Fernandes D., Takahashi R.N. Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) - the spontaneously hypertensive rat (SHR). Int J Neuropsychopharmacol 2005, 8:583-594.
47. Prieto-Gómez B., Vázquez-Alvarez A.M., Martínez-Peña J.L., Reyes-Vázquez C., Yang P.B., Dafny N. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area. Life Sci 2005, 77:635-649.
48. Rabiner D.L., Anastopoulos A.D., Costello E.J., Hoyle R.H., McCabe S.E., Swartzwelder H.S. The misuse and diversion of prescribed ADHD medications by college students. J Atten Disord 2009, 13:144-153.
49. Repantis D., Schlattmann P., Laisney O., Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 2010, 62:187-206.
50. Rimondini R., Ferré S., Giménez-Llort L., Ogren S.O., Fuxe K. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats. Eur J Pharmacol 1998, 347:153-158.
51. Rossato J.I., Bevilaqua L.R., Izquierdo I., Medina J.H., Cammarota M. Dopamine controls persistence of long-term memory storage. Science 2009, 325:1017-1020.
52. Scherer E.B., da Cunha M.J., Matté C., Schmitz F., Netto C.A., Wyse A.T. Methylphenidate affects memory, brain-derived neurotrophic factor immunocontent and brain acetylcholinesterase activity in the rat. Neurobiol Learn Mem 2010, 94:247-253.
53. Setlow B., McGaugh J.L. D2 dopamine receptor blockade immediately post-training enhances retention in hidden and visible platform versions of the water maze. Learn Mem 2000, 7:187-191.
54. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000, 24:417-463.
55. Svenningsson P., Nomikos G.G., Fredholm B.B. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci 1999, 19:4011-4022.
56. Teter C.J., McCabe S.E., LaGrange K., Cranford J.A., Boyd C.J. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006, 26:1501-1510.
57. Thai D.L., Yurasits L.N., Rudolph G.R., Perel J.M. Comparative pharmacokinetics and tissue distribution of the D-enantiomers of para-substituted methylphenidate analogs. Drug Metab Dispos 1999, 27:645-650.
58. Turner D.C., Blackwell A.D., Dowson J.H., McLean A., Sahakian B.J. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 2005, 178:286-295.
59. Tye K.M., Tye L.D., Cone J.J., Hekkelman E.F., Janak P.H., Bonci A. Methylphenidate facilitates learning-induced amygdala plasticity. Nat Neurosci 2010, 13:475-481.
60. Volz T.J., Bjorklund N.L., Schenk J.O. Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum. Synapse 2005, 57:175-178.
61. Volz T.J., Farnsworth S.J., Hanson G.R., Fleckenstein A.E. Methylphenidate-induced alterations in synaptic vesicle trafficking and activity. Ann NY Acad Sci 2008, 1139:285-290.
62. Wilens T.E., Faraone S.V., Biederman J., Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111:179-187.
63. Zhu N., Weedon J., Dow-Edwards D.L. Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats. Behav Neurosci 2007, 121:1272-1279.